Results 141 to 150 of about 248,209 (312)

COVID-19 Vaccine and Myocarditis [PDF]

open access: yesThe American Journal of Cardiology, 2021
Salah, Husam M., Mehta, Jawahar L.
openaire   +2 more sources

Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis   +4 more
wiley   +1 more source

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind   +7 more
wiley   +1 more source

Evaluating a virtual paediatric adverse drug reaction clinic

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck   +2 more
wiley   +1 more source

Attitudes toward annual COVID-19 vaccination

open access: yesDiscover Public Health
COVID-19 continues to pose a challenge to public health even after the end of the COVID-19 public health emergency in 2023. The government continues to encourage people to receive COVID-19 vaccination regularly and annual COVID-19 vaccination might ...
Filip Viskupič   +2 more
doaj   +1 more source

Access to the COVID-19 Vaccine

open access: yesInternational Journal of Environmental Research and Public Health, 2022
As of 31 August 2022, 599,825,400 confirmed coronavirus disease 2019 (COVID-19) cases and 6,469,458 deaths have been reported globally [...]
openaire   +2 more sources

Do consumers and healthcare professionals report the same adverse event differently? A paired analysis of duplicate vaccine safety reports in Norway

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim This study aimed to compare how Norwegian healthcare professionals (HCPs) and consumers reported the same adverse event (AE) following immunization with vaccines against COVID‐19 during the COVID‐19 pandemic. Specifically, we aimed to compare the extent to which HCPs and consumers reported information relevant for assessing the causal relationship ...
Tommy Emil Dzus   +4 more
wiley   +1 more source

Association between COVID-19 Booster Vaccination and COVID-19 Outcomes among U.S. Adults

open access: yesVaccines
Understanding the association between booster vaccination and COVID-19 outcomes can help strengthen post-pandemic messaging and strategies to increase vaccination and reduce severe and long-term consequences of COVID-19.
Kimberly H. Nguyen   +5 more
doaj   +1 more source

Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan [PDF]

open access: yes
Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) affects patients after recovering from acute coronavirus disease 2019 (COVID-19). This study investigates the impact of SARS-CoV-2 vaccination on PASC symptoms in children in Taiwan during ...
Ruby Pawankar   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy